Go to the Globe and Mail homepage

Jump to main navigationJump to main content


Smith & Nephew tackles a wounded rival Add to ...

Subscribers Only

Smith & Nephew is jumping on a wounded rival. The British medical technology giant has agreed to buy ArthroCare, a U.S. specialist in sports medicine, for an enterprise value of $1.5-billion (U.S.). Treating injured athletes is a faster-growing business than selling artificial hips and knees, Smith & Nephew’s traditional focus. And because of the target’s own self-inflicted injuries, the buyer is paying the slimmest of premiums.

Report Typo/Error

Next story




Most popular videos »

More from The Globe and Mail

Most popular